Feed Preview

ALS - Phenotypes

ALS - Phenotypes diagram by Kasper Kepp, PLOS One
Kasper Kepp, PLOS One

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

Top 20 most recent papers
Frontiers in Neuroscience

The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Frontiers in NeuroscienceMarch 3, 2020
Yevgeniya A AbramzonRuth Chia
14
1
Neurology. Neuroimmunology and Neuroinflammation

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis

Neurology. Neuroimmunology and NeuroinflammationMarch 4, 2020
Mads Nikolaj OlesenNasrin Asgari
1
Brain : a Journal of Neurology

CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis

Brain : a Journal of NeurologyMarch 19, 2020
Carol Dobson-StoneJohn B Kwok
62
1
Neural Regeneration Research

New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?

Neural Regeneration ResearchMarch 27, 2020
Carlos Gonzalez-FernandezFrancisco Javier Rodríguez
2
1
Biological Chemistry

The MICOS complex, a structural element of mitochondria with versatile functions

Biological ChemistryApril 2, 2020
Siavash Khosravi, Max E Harner
1
1
Biochemical and Biophysical Research Communications

Dipeptide repeat derived from C9orf72 hexanucleotide expansions forms amyloids or natively unfolded structures in vitro

Biochemical and Biophysical Research CommunicationsApril 1, 2020
Laurent BrasseurLuc Bousset
2
1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

VRK1 variants in two Portuguese unrelated patients with childhood-onset motor neuron disease

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationApril 4, 2020
Daniela Pimenta SilvaMamede de Carvalho
Annals of the Academy of Medicine, Singapore

Impact of Air Pollution and Seasonal Haze on Neurological Conditions

Annals of the Academy of Medicine, SingaporeMarch 23, 2020
Ida Ingrid RochaDeidre Anne De Silva
2
1
Physiological Measurement

A robust and novel electrical impedance metric of pulmonary function in ALS patients

Physiological MeasurementApril 3, 2020
Badria MunirSeward B Rutkove
Molekuliarnaia biologiia

Genetic Diversity in Frontotemporal Dementia

Molekuliarnaia biologiiaMarch 13, 2020
Yu A ShpilyukovaS N Illarioshkin
1
1
Acta neurologica Belgica

Amyotrophic lateral sclerosis with coexisting cancer: a single-center study

Acta neurologica BelgicaMarch 30, 2020
Onur Akan, Leyla Baysal-Kirac
Journal of Pain and Symptom Management

Dyspnea as a fatigue-promoting factor in ALS and the role of objective indicators of respiratory impairment

Journal of Pain and Symptom ManagementMarch 8, 2020
Susanne VogtMichael Brinkers
4
Journal of Neurology, Neurosurgery, and Psychiatry

Family history of neurodegenerative disorders in patients with amyotrophic lateral sclerosis: population-based case-control study

Journal of Neurology, Neurosurgery, and PsychiatryMarch 14, 2020
Catarina Falcão CamposMamede de Carvalho
1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationMarch 12, 2020
Isabel K GosseltMichael A Van Es
1
Disease Models & Mechanisms

The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice

Disease Models & MechanismsMarch 20, 2020
Valeria ValsecchiAlessandro Vercelli
2
1
Journal of Neurology, Neurosurgery, and Psychiatry

Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

Journal of Neurology, Neurosurgery, and PsychiatryMarch 6, 2020
Peggy BarschkeGerman FTLD consortium
11
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/als---phenotypes/acd563f7-12ae-43e9-8e0c-333a42dde3c3